Alteration of cellular mediated cytotoxicity, T cell receptor zeta (TcR ζ) and apoptosis related gene expression in nasopharyngeal carcinoma (NPC) patients: Possible clinical relevance

Anticancer Research

Volumn 20, Issue 2 B, 2000, Pages 1093-1100

  Laytragoon Lewin, Nongnit ^a   Porwit Macdonald, Anna ^a   Mellstedt, Håkan ^a   Lewin, Freddi ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bcl 2; LMP1; NPC; TcR

Indexed keywords

CARBOPLATIN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; INTERFERON; INTERLEUKIN 2; LATENT MEMBRANE PROTEIN 1; PROTEIN BCL 2; RECEPTOR SUBUNIT; RECOMBINANT INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CASE REPORT; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CYTOLYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MALE; MONOCYTE; NASOPHARYNX CARCINOMA; NAUSEA; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR DOWN REGULATION; VOMITING;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CARRIER PROTEINS; CELLS, CULTURED; CISPLATIN; CYTOTOXICITY, IMMUNOLOGIC; FLUOROURACIL; GENES, T-CELL RECEPTOR; HUMANS; IMMUNITY, CELLULAR; INTERFERONS; INTERLEUKIN-2; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATINS; LYMPHOCYTES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL;

EID: 0034010318     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Yu M: Nasopharyngeal carcinoma: Epidemiology and dietary factors. IARC Sci publ 105: 39-47, 1991.
2. Zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P and Santesson L: EBV DNA in biopsies of Burkitt tumors and aplastic carcinoma of the nasopharynx. Nature 228: 1056-1058, 1970.
3. Fåhraeus R, Hu LF, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T and Kallin B: Expression of Epstein-Barr virus encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42: 329-338, 1988
4. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G and Winberg G: Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 8: 1575-1583, 1993.
5. Trivedi P, Masucci M, Winberg G and Klein G: The EBV-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of the transfected murine mammary carcinoma cells. Int J Cancer 48: 794-800, 1991.
6. Hu LF, Minarovits J, Cao SL, Contreras-Salazar B, Rymo R, Falk K, Klein G and Ernberg I: Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein Barr virus BNLF-1 5′-Flanking region. J Virol 65: 1558-1567, 1991.
7. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E and Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein-1 protects infected B cells from programmed cell death. Cell 65: 1107-1115, 1991.
8. Lu QL, Elia G, Lucas S and Thomas JA: Bcl-2 proto-oncogene expression in Epstein-Barr virus associated nasopharyngeal carcinoma. Int J Cancer 53: 29-35, 1993.
9. Lu J, Chen JY, Hsu T, Yu W, Su IJ and Yang CS: Induction of apoptosis in epithelial cells by Epstein-Barr virus latent membrane protein 1. J Gen Virol 77: 1883-1892, 1996.
10. Bukowski R, Rayman P, Uzzo R, Bloom T, Sandstrom K, Peereboom D, Olencki T, Budd GT, McLain D, Elson P, Novick A and Finke J: Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: Clinical relevance and effects of cytokine therapy. Clin Cancer Res 4: 2337-2347, 1998.
11. Kurt R, Urba W, Smith JW and Schoof D: Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signalling molecules. Int J Cancer 78: 16-20, 1998.
12. Rabinowich H, Banks M, Reichert TE, Logan TF, Kirkwood JM and Whiteside TL: Expression and activity of signalling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. Clin. Cancer Res 2: 1263-1274, 1996.
13. Czader M, Mazur J, Petterson M, Liliemark J, Stromberg M, Christensson B, Tribukait B, Auer G, Ost A and Porwit A: Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas. Cancer 77: 1180-1188, 1995.
14. Mason KA, Hunter NR, Milas M, Abbruzzese JL, Milas L: Docetaxel enhances tumor radioresponse in vivo. Clin Cancer Res 3: 2431-2438, 1997.
15. Khanna R, Borrows S, Kurilla MG, Jacob CA, Misko IS, Sculley TB, eff E and Moss D: Localization of Epstein Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med 176: 169-176, 1992.
16. Matsuda M, Petersson M, Lenkei R, Taupin J, Magnusson I, Mellsetdt H, Anderson P and Kiessling R: Alteration in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease. Int J Cancer 61: 765-772, 1995.
17. Zea AH, Curti BD, Longo DL, Alvord WG, Strobl S, Mizoguchi H, Creekmore SP, O'Shea, J, Powers GC, Urba W and Ochoa AC: Alteration in T cell receptor and signal transduction molecules in melanoma patient. Clint Cancer Res 53: 1327-1335, 1995.
18. Nagagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin J, Vivier E, Anderson P and Kiessling R: Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T cells and NK cells of patients with colorectal carcinoma. Cancer Res 53: 5610-5612, 1993.
19. Reichert T, Rabinowich H, Johnson J and Whiteside T: Mechanisms responsible for signalling and functional defects. J Immunotherapy 21(4): 295-306, 1998.
20. Matsuda M, Ulfgren AK, Lenkei R, Petersson M, Ochoa AC, Lindblad S, Andersson P, Klareskog L and Kiessling R: Decreased expression of signal-transducing CD3ζ chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients. Scand J Immunol 47: 254-262, 1998.
21. Kono K, Salazar F, Petersson M, Hanson J, Masucci G, Nakazawa T, Wasserman K, Anderson P and Kiessling R: Hydrogen peroxide secreted by tumor-derived macrophages down-regulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and NK mediated cytotoxicity. Eur J Immunol 26: 1308-1313, 1996.
22. Otsuji M, Kimura Y, Aoe T, Okamoto Y, and Saito T: Oxidative stress by tumor-derived macrophages suppresses the expression of CD3ζ chains of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci USA 93: 13119-13124, 1996.
23. Renner C, Ohnesorge S, Held G, Bauer S, Jung W, Pfitzenmeier J and Pfreundschuh M: T cells from patients with Hodgkin's disease have a defective T cell receptor ζ chains expression that is reversible by T cell stimulation with CD3 and CD28. Blood 88: 236-241, 1996.